IL-13 induces expression of CD36 in human monocytes through PPARgamma activation

Eur J Immunol. 2007 Jun;37(6):1642-52. doi: 10.1002/eji.200636625.

Abstract

The class B scavenger receptor CD36 is a component of the pattern recognition receptors on monocytes that recognizes a variety of molecules. CD36 expression in monocytes depends on exposure to soluble mediators. We demonstrate here that CD36 expression is induced in human monocytes following exposure to IL-13, a Th2 cytokine, via the peroxisome proliferator-activated receptor (PPAR)gamma pathway. Induction of CD36 protein was paralleled by an increase in CD36 mRNA. The PPARgamma pathway was demonstrated using transfection of a PPARgamma expression plasmid into the murine macrophage cell line RAW264.7, expressing very low levels of PPARgamma, and in peritoneal macrophages from PPARgamma-conditional null mice. We also show that CD36 induction by IL-13 via PPARgamma is dependent on phospholipase A2 activation and that IL-13 induces the production of endogenous 15-deoxy-Delta12,14-prostaglandin J2, an endogenous PPARgamma ligand, and its nuclear localization in human monocytes. Finally, we demonstrate that CD36 and PPARgamma are involved in IL-13-mediated phagocytosis of Plasmodium falciparum-parasitized erythrocytes. These results reveal a novel role for PPARgamma in the alternative activation of monocytes by IL-13, suggesting that endogenous PPARgamma ligands, produced by phospholipase A2 activation, could contribute to the biochemical and cellular functions of CD36.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anilides / pharmacology
  • Animals
  • Arachidonic Acids / pharmacology
  • CD36 Antigens / genetics
  • CD36 Antigens / metabolism*
  • Cell Line, Tumor
  • DNA / metabolism
  • Enzyme Inhibitors / pharmacology
  • Erythrocytes / drug effects
  • Erythrocytes / parasitology
  • Gene Expression / drug effects
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Interleukin-13 / pharmacology*
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Mice
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • Organophosphonates / pharmacology
  • PPAR gamma / agonists
  • PPAR gamma / antagonists & inhibitors
  • PPAR gamma / physiology*
  • Phagocytosis / drug effects
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A2
  • Plasmodium falciparum / physiology
  • Prostaglandin D2 / analogs & derivatives
  • Prostaglandin D2 / metabolism
  • Prostaglandin D2 / pharmacology
  • Protein Binding / drug effects
  • Rosiglitazone
  • Thiazolidinediones / pharmacology
  • Transfection

Substances

  • 15-deoxyprostaglandin J2
  • 2-chloro-5-nitrobenzanilide
  • Anilides
  • Arachidonic Acids
  • CD36 Antigens
  • Enzyme Inhibitors
  • Hypoglycemic Agents
  • Interleukin-13
  • Organophosphonates
  • PPAR gamma
  • Thiazolidinediones
  • methyl arachidonylfluorophosphonate
  • Rosiglitazone
  • DNA
  • Phospholipases A
  • Phospholipases A2
  • Prostaglandin D2